BCI Marketplace
Depression Neuromodulation trials

DBS for Depression

RecruitingNCT03437928Phase: NAStarted 2019-08-20

Summary

The goal of the study is to address the unmet need of TRD patients by identifying brain networks critical for treating depression and to use next generation precision DBS with steering capability to engage these targeted networks. The study's goal will be achieved through 3 specific aims: 1. Demonstrate device capability to selectively and predictably engage distinct brain networks 2. Delineate depression-relevant networks and demonstrate behavioral changes with network-targeted stimulation 3.

Eligibility

Sex
ALL
Min Age
22 Years
Max Age
70 Years

Inclusion Criteria: 1. Men and women (non-pregnant) between ages 22 and 70; 2. DSM-5 diagnosis (assessed by Structured Clinical Interview for DSM-5 Axis I disorders SCID-5) of major depression disorder (MDD) as the primary diagnosis. A current major depressive episode (MDE), recurrent or single epi

Locations

University of Texas Southwestern
Dallas, Texas, United States
Baylor College of Medicine
Houston, Texas, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →